Shraboni Ghosal

Oct 31, 2024 | bjgp.org | Shraboni Ghosal |Neil Heron |Kayleigh J. Mason |James Bailey

AbstractBackground Orlistat is recommended as an adjunct to diet and exercise for weight loss in the treatment of type 2 diabetes mellitus (T2DM). Aim To explore associations between patient characteristics and orlistat prescribing, and to determine associations of orlistat with weight loss in T2DM and prediabetes. Design and setting Cohort study using anonymised health records from a UK database of general practice.

Sep 12, 2024 | bjgp.org | Neil Heron |Kayleigh J. Mason |James Bailey |Shraboni Ghosal

body mass index obesity prediabetes primary care type 2 diabetes weight loss Introduction Type 2 diabetes mellitus (T2DM) is a major public health burden and remains a health challenge globally.1 In the UK, diabetes diagnoses have more than doubled in the past 15 years to >5 million people having a diabetes diagnosis in 2024.2 Prediabetes prevalence has more than tripled, with 30% of adults — or one in nine — in England having prediabetes in 2024.3 Diabetes-related complications — such as...